General Session
Reversing Chemoresistance in Platinum-Resistant Ovarian Cancer: The Role of Glucocorticoid-Receptor Modulation and Other Emerging Therapeutic Pathways
45 min
Saturday, September 26, 2026
3:30 PM - 4:15 PM
Supported by an educational grant from Corcept Therapeutics, Inc.
-
Presenter
-
